Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Neurocrine

Ionis Pharmaceuticals Touts $3B TRYNGOLZA Opportunity, Pipeline Readouts at Conference

Executives at a healthcare investor event outlined commercial launch plans, pipeline readouts and market-development priorities across several biotechnology franchises, with discussion spanning Ionis Pharmaceuticals (NASDAQ:IONS) products including TRYNGOLZA, DAWNZERA and WAINUA, as well as Neurocri

MarketBeat

3 Biotech Stocks to Watch: Iovance, Neurocrine & Viking

Timing matters with biotech stocks; these three companies offer distinct risk-reward profiles but have upcoming catalysts that could redefine their value

MarketBeat

3 Top Growth Stocks to Buy at a Discount This Month

According to analysts, here are three top-notch mid-cap growth stocks to snag at a discount now.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Leading Welsh life sciences company Diurnal in £48m takeover by US firm

The board of Diurnal have recommended the takeover bid from Neurocrine

Birmingham Post

Why Neurocrine Biosciences Are Trading Higher Today?

Neurocrine Biosciences Inc (NASDAQ: NBIX) reported

Organisations

Ionis Pharmaceuticals

19 stories

NBIX

17 stories

Neurocrine Biosciences

12 stories

Neurocrine Biosciences Inc

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

biotechnology

279 stories

Read news from The Economist, FT, and more,
with one subscription

Places

United States

399,381 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.